NCT02995772View on ClinicalTrials.gov

Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Breast Cancer
Interventions
DRUG

Aromatase Inhibitors (Arimidex)

Comparison of efficacy with chemotherapy

DRUG

Tamoxifen

Comparison of efficacy with chemotherapy

PROCEDURE

SOB

Comparison of efficacy with chemotherapy

DRUG

FAC

Comparison of efficacy with hormonal therapy

DRUG

Aromatase Inhibitors (Femara)

Comparison of efficacy with chemotherapy

DRUG

Aromatase Inhibitors (Aromasin)

Comparison of efficacy with chemotherapy

Trial Locations (1)

11420

Dharmais National Cancer Center Hospital, Jakarta

All Listed Sponsors
lead

Dharmais National Cancer Center Hospital

OTHER_GOV

NCT02995772 - Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients | Biotech Hunter | Biotech Hunter